Sporadic medullary microcarcinoma of the thyroid: a retrospective analysis of eighty cases. 1998

N Beressi, and J M Campos, and J P Beressi, and B Franc, and P Niccoli-Sire, and B Conte-Devolx, and A Murat, and P Caron, and L Baldet, and J L Kraimps, and R Cohen, and J C Bigorgne, and O Chabre, and P Lecomte, and E Modigliani
Department of Endocrinology, University Paris XIII, Hopital Avicenne, Bobigny, France.

Clinical characteristics and prognosis of 80 patients (53 women and 27 men) with sporadic medullary thyroid carcinomas (MTC), less than 1 cm in size (micro-MTC), operated on between 1971 and 1996 are reported (73 total and 7 partial thyroidectomies). These patients, obtained from a national database of 899 patients with MTC, were compared with 357 cases of sporadic MTC greater than 1 cm and 149 subjects with familial MTC less than 1 cm (familial micro-MTC). Median age at surgery was 52.5 years, a distribution similar to larger sporadic MTC. Micro-MTC was identified due to elevated calcitonin (47.5%), clinically identified lymph node (10.0%), distant metastases (6.3%) or pathologic finding at surgery (36.2%). Diarrhea and/or flushing were observed in 6 patients including 4 with clinically identified lymph node. Among patients who had lymph node dissection at surgery (68.8%), lymph node involvement with tumor was observed in 30.9%, and was significantly more frequent in multifocal (7/11) than in unifocal micro-MTC (p < 0.03). All sporadic micro-MTC were unilateral. Survival rate was 93.9% +/- 4.4% (SE) at 10 years, greater than that observed in sporadic macro-MTC (p = 0.04). Normal postoperative basal calcitonin (CT) was obtained in 71.1% of micro-MTC patients versus 33.6% in sporadic macro-MTC (p < 0.01). Sporadic micro-MTC is much more frequent than expected, 15% of MTC in our series. Although specific survival rate and percentage of biological cure in micro-MTC are significantly better than for larger tumors, the frequency of lymph node involvement, however, justifies an aggressive surgical approach including total thyroidectomy and bilateral central lymph node dissection.

UI MeSH Term Description Entries
D008207 Lymphatic Metastasis Transfer of a neoplasm from its primary site to lymph nodes or to distant parts of the body by way of the lymphatic system. Lymph Node Metastasis,Lymph Node Metastases,Lymphatic Metastases,Metastasis, Lymph Node
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D005260 Female Females
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000293 Adolescent A person 13 to 18 years of age. Adolescence,Youth,Adolescents,Adolescents, Female,Adolescents, Male,Teenagers,Teens,Adolescent, Female,Adolescent, Male,Female Adolescent,Female Adolescents,Male Adolescent,Male Adolescents,Teen,Teenager,Youths
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults
D012189 Retrospective Studies Studies used to test etiologic hypotheses in which inferences about an exposure to putative causal factors are derived from data relating to characteristics of persons under study or to events or experiences in their past. The essential feature is that some of the persons under study have the disease or outcome of interest and their characteristics are compared with those of unaffected persons. Retrospective Study,Studies, Retrospective,Study, Retrospective
D013964 Thyroid Neoplasms Tumors or cancer of the THYROID GLAND. Cancer of Thyroid,Thyroid Cancer,Cancer of the Thyroid,Neoplasms, Thyroid,Thyroid Adenoma,Thyroid Carcinoma,Adenoma, Thyroid,Adenomas, Thyroid,Cancer, Thyroid,Cancers, Thyroid,Carcinoma, Thyroid,Carcinomas, Thyroid,Neoplasm, Thyroid,Thyroid Adenomas,Thyroid Cancers,Thyroid Carcinomas,Thyroid Neoplasm
D016019 Survival Analysis A class of statistical procedures for estimating the survival function (function of time, starting with a population 100% well at a given time and providing the percentage of the population still well at later times). The survival analysis is then used for making inferences about the effects of treatments, prognostic factors, exposures, and other covariates on the function. Analysis, Survival,Analyses, Survival,Survival Analyses

Related Publications

N Beressi, and J M Campos, and J P Beressi, and B Franc, and P Niccoli-Sire, and B Conte-Devolx, and A Murat, and P Caron, and L Baldet, and J L Kraimps, and R Cohen, and J C Bigorgne, and O Chabre, and P Lecomte, and E Modigliani
October 1992, Histopathology,
N Beressi, and J M Campos, and J P Beressi, and B Franc, and P Niccoli-Sire, and B Conte-Devolx, and A Murat, and P Caron, and L Baldet, and J L Kraimps, and R Cohen, and J C Bigorgne, and O Chabre, and P Lecomte, and E Modigliani
January 2003, The American journal of surgical pathology,
N Beressi, and J M Campos, and J P Beressi, and B Franc, and P Niccoli-Sire, and B Conte-Devolx, and A Murat, and P Caron, and L Baldet, and J L Kraimps, and R Cohen, and J C Bigorgne, and O Chabre, and P Lecomte, and E Modigliani
September 2005, European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology,
N Beressi, and J M Campos, and J P Beressi, and B Franc, and P Niccoli-Sire, and B Conte-Devolx, and A Murat, and P Caron, and L Baldet, and J L Kraimps, and R Cohen, and J C Bigorgne, and O Chabre, and P Lecomte, and E Modigliani
June 2000, The American journal of surgical pathology,
N Beressi, and J M Campos, and J P Beressi, and B Franc, and P Niccoli-Sire, and B Conte-Devolx, and A Murat, and P Caron, and L Baldet, and J L Kraimps, and R Cohen, and J C Bigorgne, and O Chabre, and P Lecomte, and E Modigliani
October 2001, The American journal of surgical pathology,
N Beressi, and J M Campos, and J P Beressi, and B Franc, and P Niccoli-Sire, and B Conte-Devolx, and A Murat, and P Caron, and L Baldet, and J L Kraimps, and R Cohen, and J C Bigorgne, and O Chabre, and P Lecomte, and E Modigliani
February 2012, Cancer,
N Beressi, and J M Campos, and J P Beressi, and B Franc, and P Niccoli-Sire, and B Conte-Devolx, and A Murat, and P Caron, and L Baldet, and J L Kraimps, and R Cohen, and J C Bigorgne, and O Chabre, and P Lecomte, and E Modigliani
February 2022, European review for medical and pharmacological sciences,
N Beressi, and J M Campos, and J P Beressi, and B Franc, and P Niccoli-Sire, and B Conte-Devolx, and A Murat, and P Caron, and L Baldet, and J L Kraimps, and R Cohen, and J C Bigorgne, and O Chabre, and P Lecomte, and E Modigliani
May 2024, Zhonghua yi xue za zhi,
N Beressi, and J M Campos, and J P Beressi, and B Franc, and P Niccoli-Sire, and B Conte-Devolx, and A Murat, and P Caron, and L Baldet, and J L Kraimps, and R Cohen, and J C Bigorgne, and O Chabre, and P Lecomte, and E Modigliani
May 2012, The Journal of clinical endocrinology and metabolism,
N Beressi, and J M Campos, and J P Beressi, and B Franc, and P Niccoli-Sire, and B Conte-Devolx, and A Murat, and P Caron, and L Baldet, and J L Kraimps, and R Cohen, and J C Bigorgne, and O Chabre, and P Lecomte, and E Modigliani
October 2017, World journal of surgery,
Copied contents to your clipboard!